Cargando…
mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9
OBJECTIVE: The aim of the study was to investigate molecular mechanisms underlying the role of miR-126-5p in cisplatin (DDP) sensitivity of non-small-cell lung cancer (NSCLC). METHODS: The expression of miR-126-5p and ADAM9 in NSCLC cancer tissues and adjacent tissues, cisplatin-sensitive and drug-r...
Autores principales: | Liu, Bo, Wang, Rui, Liu, Hongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147552/ https://www.ncbi.nlm.nih.gov/pubmed/34055989 http://dx.doi.org/10.1155/2021/6622342 |
Ejemplares similares
-
MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9
por: Hua, Yibo, et al.
Publicado: (2018) -
MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9
por: Jia, A Y, et al.
Publicado: (2014) -
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma
por: Felli, Nadia, et al.
Publicado: (2013) -
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
por: Caporali, Simona, et al.
Publicado: (2019) -
Tubeimoside-1 inhibits the proliferation and metastasis by promoting miR-126-5p expression in non-small cell lung cancer cells
por: Shi, Hanbing, et al.
Publicado: (2018)